Suppr超能文献

肝内胆管细胞癌:可切除性的局限性、当前的手术概念和未来的观点。

Intrahepatic cholangiocarcinoma: Limitations for resectability, current surgical concepts and future perspectives.

机构信息

Department of HPB Surgery and Liver Transplant, Royal Free London, London, United Kingdom.

Department of General, Visceral and Transplant Surgery, University Medical Center of the Johannes Gutenberg, University Mainz, Mainz, Germany.

出版信息

Eur J Surg Oncol. 2020 May;46(5):740-746. doi: 10.1016/j.ejso.2020.01.028. Epub 2020 Jan 23.

Abstract

Intrahepatic cholangiocarcinoma (iCCA) is the second most common hepatic malignancy and its incidence has been shown to increase significantly during the past decades. Complete surgical resection is currently acknowledged as the only curative treatment option able to provide adequate long-term outcomes. We herein review technical, functional and oncologic limitations for resectability, discuss current surgical aspects as well as highlight the fields in which future research and practice should focus on in order to ameliorate long-term outcomes in patients with iCCA.

摘要

肝内胆管细胞癌(iCCA)是第二常见的肝脏恶性肿瘤,其发病率在过去几十年中显著增加。目前,完全手术切除被认为是唯一能够提供充分长期疗效的治愈性治疗选择。本文回顾了 iCCA 可切除性的技术、功能和肿瘤学限制,讨论了当前的手术方面,并强调了未来研究和实践应关注的领域,以改善 iCCA 患者的长期疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验